Correlation of abnormal menses and insulin resistance;Correlación de trastornos menstruales y resistencia a la insulina

Ginecologia y Obstetricia de Mexico

Volumn 71, Issue JUNE, 2003, Pages 312-317

  González Centeno, Andrés ^a   Nahum Hernández, M Pedro ^a   Mendoza, Rosario M ^a   Ayala, Aquiles R ^a  

^a HOSPITAL JUÁREZ DE MÉXICO   (Mexico)

Author keywords

Abnormal menses; Insulin resistance

Indexed keywords

GLUCOSE; INSULIN;

ACANTHOSIS NIGRICANS; ADULT; ARTICLE; BIOCHEMISTRY; BODY MASS; CONTRACEPTION; CONTROLLED STUDY; CORRELATION ANALYSIS; ECHOGRAPHY; ENDOCRINE DISEASE; EVALUATION; FEMALE; HORMONE DETERMINATION; HUMAN; HYPERANDROGENISM; INSULIN RESISTANCE; LIPID ANALYSIS; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; MENSTRUATION; MENSTRUATION DISORDER; MEXICO; OBESITY; OBSERVATION; OVARY POLYCYSTIC DISEASE; OVARY TUMOR; PELVIC DISEASE; REPRODUCTION; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; SYMPTOMATOLOGY; UTERUS TUMOR;

ACANTHOSIS NIGRICANS; ADOLESCENT; ADULT; AMENORRHEA; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; HYPERLIPIDEMIAS; INSULIN RESISTANCE; MENSTRUATION DISTURBANCES; MEXICO; OBESITY; POLYCYSTIC OVARY SYNDROME; RETROSPECTIVE STUDIES;

EID: 0141626862     PISSN: 03009041     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Bravender T, Emans J. Menstrual Disorders. Pediat Clin NA 1999; 46: 545-53.
2. Pletcher J, Slap G. Menstrual Disorders. Pediat Clin NA 1999; 46: 505-17.
3. Solomon C, Hu F, Dunaif A, Rich-Edwards J, Willet W, Hunter D, Colditz G, Speizer F, Manson J. Long or Highly irregular menstrual cycles as a marker for risk of type 2 diabetes mellitus. JAMA 2001; 286: 2423-26.
4. McFarlane S, Banerji M, Sowers J. Insulin Resistance and cardiovascular disease. J Clin Endocrinol Metabol 2001; 86: 713-8.
5. Jakubowicz D, Seppala M, Jakubowicz S, Rodriguez O, Rivas-Santiago A, Koistinen R, Nestler J and Kostinien H. Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J Clin Endocrinol Metabol 2001; 86: 1126-33.
6. Klein N, Battaglia D, Woodruff T, Padmanabhan V, Guidice L, Bremner W, Soules M. Ovarian Follicular concentrations of activin, follistatin, inhibin, insulin-like Growth factor I (IGF-1) IGF-II, IGF-Binding Protein-2 (IGFBP-2), IGFBP-3, and vascular endothelial growth factor in spontaneous menstrual cycles of normal women of advanced reproductive age. J Clin Endocrinol Metabol. 2000; 85: 4520-5.
7. Owens D, Zinman B, Bolli G. [Review] Insulins today and behyond. The Lancet 2001; 358: 739-46.
8. Hirshoren N, Tzoran I, Makrienko I, Edoute Y, Plawner M, Itskovitz-Eldor J, Jacob G. Menstrual cycle effects on the neurohumoral and autonomic nervous systems regulating the cardiovascular system. J Clin Endocrinol Metab 2002; 87: 1569-75.
9. Voorhorst, Kaptein M, Hirasing R, Koppenaal C, Schoemaker J. Insulin, Androgen and Gonadotropin concentration, body mass index, and waist to hip ratio in the first years after menarche in girls with regular. J Clin Endocrinol Metabol 2000; 85: 1394-400.
10. Zacur H. A. Polycystic Ovary Syndrome Hyperandrogenism, and insulin resistance. Obstet Gynecol Clin NA 2001; 28: 21-33.
11. Moghetti P, Castello R, Negri C, Tosi F, Perrone F, Caputo M, Zanolin E, Muggeo. Metformin effects on clinical features, endocrine and metabolic profiles, and insulin sensitivitiy in polycystic ovary syndrome: A randomized, double-blind, placebo-controlled 6 Month trial, followed by open, long-term clinical evaluation. J Clin Endocrinol Metabol 2000; 85: 139-46.
12. Frankovich R, Lebrun C. Menstrual cycle, contraception, and performance. Clin Sports Med 2000; 19: 456-651.
13. Legro R, Bentley-Lewis R, Driscoll D, Wang S, Dunaif A. Insulin Resistance in the Sister of Women with Polycystic Ovary Syndrome: Association with Hyperandrogenemia Rather Than Menstrual Irregularity. J Clin Endocrinol Metabol 2002; 87: 2013-7.
14. Solomon C, Hu FB, Dunaif A, Rich-Edwards J, Stampfer M, Willett W, Speizer F, Manson J. Menstrual cycle irregularity and Risk for future cardiovascular Disease. J Clin Endocrinol Metabol 2002; 87: 2128-33.
15. Pierre J, Lemieux I, Denis P. Treatment of obesity: need to focus on high risk abdominally obese patients. Clinical review. BMJ 2001; 322: 716-20.
16. Hatch R, Rosenfield R, Kim M, Tredway D. Hirsutism: Implications, etiology and management. Am J Obstet Gynecol. 1981; 140: 815-30.
17. Haffner S, González C, Mettinen H, Kennedy E, Stern M. A prospective analysis of the HOMA model. Diabetes Care 1996; 19: 1138-41.
18. Yann R. Frederique D. Loic G, Yves A. Laurent L, Didier D. Ultrasound assessment of ovarian stroma hypertrophy in hyperandrogenism and ovulation disorders: visual analysis versus computerized quantification. Fertil Steril 1995; 64: 307-12.